Organization
Dynavax Technologies Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Dynavax Technologies Corp.
... BERKELEY, Calif., Jan. 12, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that on January 10, 2018 the Compensation Committee ...
... BERKELEY, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that HEPLISAV-B„¢ [Hepatitis B Vaccine (Recombinant), Adjuvanted] is ...
... BERKELEY, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that Eddie Gray, Dynavax's chief executive officer, will ...
... Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that on November 28, 2017 the Compensation Committee ...
... of Starbucks Corporation (NASDAQ:SBUX), Home Depot, Inc. (NYSE:HD), Kroger Company (NYSE:KR), Dynavax Technologies Corporation (NASDAQ:DVAX), Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), and Medtronic PLC ...
... Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that Eddie Gray, Dynavax's chief executive officer, will ...
... into collaborations for increasing their portfolio and global presence. For example, Dynavax Technologies Corporation and Merck are together investigating potential synergistic effects of drug developed ...
... If you want a Stock Review on DVAX, KERX, MBRX, or TGTX then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... 1. Dynavax Technologies received FDA approval for its two-dose hepatitis B vaccine Heplisav-B, following ...
... is measured by the watch in addition to other biometrics. (Fortune) INDICATIONS Dynavax finally scores win for its hepatitis B vaccine. The third time was ...
... Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) ...
... Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the third quarter ended September ...
... Dynavax Technologies Corporation (NASDAQ: DVAX) announced initiation of dosing in a phase 1B dose escalation ...
... If you want a Stock Review on DVAX, KERX, MBRX, or ZIOP then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... court on Tuesday tossed a proposed class action alleging biopharmaceutical company Dynavax Technologies Corp. misrepresented the safety of its Heplisav vaccine for hepatitis B, eventually ...
... If you want a Stock Review on CELG, DVAX, KERX, or MBRX then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... settlement in a shareholder derivative action has been reached with Dynavax Technologies Corporation (NASDAQ: DVAX). The Superior Court of the State of California, County of ...
... Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that the company will present at two upcoming ...
... settlement in a shareholder derivative action has been reached with Dynavax Technologies Corporation (NASDAQ: DVAX). The Superior Court of the State of California, County of ...
... feasibility work it has signed an exclusive global agreement with Dynavax Technologies Corporation (NASDAQ: DVAX; 'Dynavax'), a clinical stage immunotherapy company, for the clinical application ...
... financing round by July 2018. Statement > Vectura landed a deal with Dynavax. The agreement clears Dynavax to use Vectura’s nebulizer to administer a TLR9 ...
... FTSE 250 maker of respiratory devices, yesterday announced an exclusive agreement with Dynavax for the clinical application of its technology to treat lung cancer. Shares ...
... Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the completion of an underwritten public offering of ...
... Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it intends to offer and sell $125.0 ...
Want to see the full history on Dynavax Technologies Corp.? Upgrade to RelSci Pro now!
Start My Free Trial